Edwards, Medtronic bolster economic, clinical case for using TAVR over surgery

Edwards Lifesciences and Medtronic have bolstered the case for using their transcatheter aortic valve replacement devices rather than traditional surgery, using this year's Transcatheter Cardiovascular Therapeutics conference to present results that point to clinical and cost-saving advantages.